Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezekowitz

Showing results (91-100 of 1,022) with videos related to

Pageof 103
Sort By:
The Canadian Journal of Cardiology|February 26, 2014
Risk stratification in acute heart failureDouglas S Lee, Justin A Ezekowitz
Circulation. Heart Failure|January 13, 2017
Composite End Points in Clinical Trials of Heart Failure Therapy: How Do We Measure the Effect Size?Paul M Brown, Justin A Ezekowitz
Current Opinion in Cardiology|December 24, 2002
Anticoagulation in management of atrial fibrillationMichael D Ezekowitz, Pavlo I Netrebko
Journal of Cell Science. Supplement|January 1, 1988
The structure and function of vertebrate mannose lectin-like proteinsR A Ezekowitz, P D Stahl
Transfusion|January 1, 1986
Indium-111 labeling of stored platelet concentratesM D Ezekowitz, E O Smith
Cardiology in Review|February 15, 2001
Approach to management of the patient over age 75 with atrial fibrillationH I Michelena, M D Ezekowitz
Nutrition (Burbank, Los Angeles County, Calif.)|July 13, 2015
Re. "Dietary fatty acids intake and mortality in patients with heart failure": Authors' responseEloisa Colin-Ramirez, Justin A Ezekowitz
JAMA|May 26, 1999
Preventing stroke in patients with atrial fibrillationM D Ezekowitz, J A Levine
Cardiology Clinics|November 1, 1996
Prevention of thromboembolism in patients with atrial fibrillationI S Cohen, M D Ezekowitz
Circulation|April 12, 2017
Letter by Brown and Ezekowitz Regarding Article, "Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective"Paul M Brown, Justin A Ezekowitz
Pageof 103

Showing results (91-100 of 1,022) with videos related to

Sort By:
Pageof 103
The Canadian Journal of Cardiology|February 26, 2014
Risk stratification in acute heart failureDouglas S Lee, Justin A Ezekowitz
Circulation. Heart Failure|January 13, 2017
Composite End Points in Clinical Trials of Heart Failure Therapy: How Do We Measure the Effect Size?Paul M Brown, Justin A Ezekowitz
Current Opinion in Cardiology|December 24, 2002
Anticoagulation in management of atrial fibrillationMichael D Ezekowitz, Pavlo I Netrebko
Journal of Cell Science. Supplement|January 1, 1988
The structure and function of vertebrate mannose lectin-like proteinsR A Ezekowitz, P D Stahl
Transfusion|January 1, 1986
Indium-111 labeling of stored platelet concentratesM D Ezekowitz, E O Smith
Cardiology in Review|February 15, 2001
Approach to management of the patient over age 75 with atrial fibrillationH I Michelena, M D Ezekowitz
Nutrition (Burbank, Los Angeles County, Calif.)|July 13, 2015
Re. "Dietary fatty acids intake and mortality in patients with heart failure": Authors' responseEloisa Colin-Ramirez, Justin A Ezekowitz
JAMA|May 26, 1999
Preventing stroke in patients with atrial fibrillationM D Ezekowitz, J A Levine
Cardiology Clinics|November 1, 1996
Prevention of thromboembolism in patients with atrial fibrillationI S Cohen, M D Ezekowitz
Circulation|April 12, 2017
Letter by Brown and Ezekowitz Regarding Article, "Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure: A 20-Year Perspective"Paul M Brown, Justin A Ezekowitz
Pageof 103